DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
GnRH signaling pathway	R-HSA-168638	map04912	flucloxacillin	6231	drug-path
Long-term depression	R-HSA-9620244	map04730	flucloxacillin	6231	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	flucloxacillin	6231	drug-path
Huntington's disease	R-HSA-1643685	0	flucloxacillin	6231	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	flucloxacillin	6231	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	canavanine	35370	drug-path
Olfactory transduction	R-HSA-9751605	map04740	canavanine	35370	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	canavanine	35370	drug-path
Cell cycle	R-HSA-1640170	map04110	canavanine	35370	drug-path
Tight junction	R-HSA-2134514	map04530	canavanine	35370	drug-path
Long-term potentiation	R-HSA-9620244	map04720	canavanine	35370	drug-path
Parkinson's disease	R-HSA-1643685	0	canavanine	35370	drug-path
Olfactory transduction	R-HSA-9751605	map04740	astemizole	2247	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	astemizole	2247	drug-path
Circadian rhythm - mammal	R-HSA-400253	0	astemizole	2247	drug-path
Bladder cancer	R-HSA-9700206	map05219	astemizole	2247	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	astemizole	2247	drug-path
Parkinson's disease	R-HSA-1643685	0	astemizole	2247	drug-path
Alzheimer's disease	R-HSA-1643685	0	mefloquine	6291	drug-path
Huntington's disease	R-HSA-1643685	0	mefloquine	6291	drug-path